a.coelho
TL2 Moderator · Kraków
Contributes reviews on supplier material. Based in Kraków.
Joined 23 August 2025 · last posted 1d · groups: regional-apac
84 posts, newest first. Showing up to 150.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #129 · Analytics › Home & field testing · 27 Jul 2026 · 3 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
What a certificate commits its issuer to Replied, post #67 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes On post #63 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
[2026 update] Journal club: FLOW and the renal composite, component by component Replied, post #3 · Evidence › Journal club · 19 Jul 2026 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #97 · Sourcing › Independent verification · 16 Jul 2026 · 17 likes I read post #95 twice before replying, because I had assumed the opposite. Medutest: combined purity and identity reporting. Appears throughout vendor documentation.…
-
What a reversed-phase purity number actually is Replied, post #57 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #39 · Wellbeing › Sleep · 27 Jun 2026 · 12 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #131 · Practice › Interactions · 22 Jun 2026 · 20 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Publication patterns in the BPC-157 literature, examined Replied, post #16 · Compounds › Repair & healing peptides · 18 Jun 2026 · 0 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #47 · Access › Pricing · 7 Jun 2026 · 17 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
A structured critique template this community uses — a second dataset Replied, post #4 · Evidence › Study critique · 5 Jun 2026 · 10 likes Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Micronutrient adequacy at low total intake Replied, post #4 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 18 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #41 · Outcomes › Progress reports · 23 May 2026 · 0 likes On post #37 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #59 · Evidence › Journal club · 17 May 2026 · 4 likes post #58 is right about the mechanism and I think understates the practical bit. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference…
-
GLP-1 receptor distribution: central and peripheral Replied, post #51 · Pharmacology › Receptor biology · 17 May 2026 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
How this community labels and discusses unrefereed work — the long version Replied, post #12 · Evidence › Preprints · 12 May 2026 · 8 likes post #11 answers the question as asked. The question underneath it is different. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Official shortage notices and what they authorise Replied, post #39 · Access › Shortages · 8 May 2026 · 6 likes On post #35 — agreed on the reasoning, with one qualification. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #32 · Devices › Syringes & needles · 5 May 2026 · 20 likes Worth separating two things that post #28 runs together. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an…
-
Managing an unplanned gap in supply Replied, post #86 · Access › Shortages · 5 Apr 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #54 · Clinical › Comorbidities · 3 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Grapefruit: why this class is not the class that cares Replied, post #108 · Practice › Interactions · 1 Apr 2026 · 31 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #15 · Practice › Administration · 12 Mar 2026 · 0 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #41 · Compounds › Semaglutide · 5 Mar 2026 · 16 likes On post #37 — agreed on the reasoning, with one qualification. Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the…
-
The lowest dose that does anything: is that a real question? Replied, post #30 · Practice › Dosing & titration · 3 Mar 2026 · 4 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Measurement error in a self-reported exposure Replied, post #120 · Evidence › Study critique · 27 Feb 2026 · 7 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #5 · Practice › Administration · 27 Feb 2026 · 15 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Request: export my own posts — one year on Replied, post #47 · Meta › Feature requests · 15 Feb 2026 · 12 likes I read post #45 twice before replying, because I had assumed the opposite. Deprecation requests: if you think a feature should be removed or changed, that is also a…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #4 · Compounds › Semaglutide · 11 Feb 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #2 · marked as the solution · Compounds › Semaglutide · 11 Feb 2026 · 33 likes the opening post is right about the mechanism and I think understates the practical bit. The SELECT trial changed the positioning because it was the first…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #127 · Analytics › Home & field testing · 6 Feb 2026 · 13 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #95 · Practice › Side effects · 14 Jan 2026 · 3 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #76 · Practice › Side effects · 11 Jan 2026 · 3 likes I read post #74 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #10 · Research Methods › Statistics · 10 Jan 2026 · 33 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #29 · Evidence › Trials · 28 Dec 2025 · 8 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #8 · Regional › UK & Ireland · 23 Dec 2025 · 4 likes This follows post #5 rather than contradicting it. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #7 · Data & Tools › Calculators · 21 Dec 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
[2026 update] Whether protein timing matters at a large deficit Replied, post #9 · Nutrition & Training › Protein & intake · 20 Dec 2025 · 6 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #15 · Compounds › Semaglutide · 11 Dec 2025 · 0 likes Worth separating two things that post #11 runs together. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #3 · Compounds › Oral incretins · 13 Nov 2025 · 2 likes post #2 is right about the mechanism and I think understates the practical bit. Trial adherence in an oral trial with strict administration requirements is genuinely…
-
Temperature loggers worth the money Replied, post #49 · Devices › Cold chain · 1 Nov 2025 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading SURMOUNT-1 without the press release Replied, post #33 · Compounds › Tirzepatide · 13 Oct 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Compounds this community declines to help with, and why Replied, post #59 · Compounds › Other compounds · 4 Oct 2025 · 9 likes This follows post #56 rather than contradicting it. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another.…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #18 · Compounds › Other compounds · 1 Oct 2025 · 0 likes post #17 answers the question as asked. The question underneath it is different. When "no data" is the complete and final answer: if there is no published human data on…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #93 · Evidence › Study critique · 15 Sep 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #83 · Compounds › Retatrutide · 7 Sep 2025 · 21 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Titles that describe the question, not the situation — what changed since Started this topic · Start Here › How to Ask · 7 Sep 2025 · 0 likes Posting this under the heading it deserves: Titles that describe the question, not the situation — what changed since Everything below is what sits behind that.…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #35 · Compounds › Tirzepatide · 3 Sep 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #27 · Practice › Storage & stability · 18 Aug 2025 · 0 likes post #26 answers the question as asked. The question underneath it is different. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles,…
-
When a preprint is the best available evidence and we say so Replied, post #47 · Evidence › Preprints · 12 Aug 2025 · 0 likes Picking up post #44: that is the part I would want checked first. Preprints for speed: some important preliminary findings are posted as preprints to disseminate…
-
How to research a compound with no human data without deceiving yourself Replied, post #115 · Compounds › Other compounds · 5 Aug 2025 · 27 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #89 · Compounds › Retatrutide · 3 Aug 2025 · 2 likes post #88 is right about the mechanism and I think understates the practical bit. Dose escalation in the published trials: the protocols started at lower doses and…
-
A field-by-field walk through a certificate of analysis Replied, post #56 · Analytics › COA interpretation · 16 Jul 2025 · 21 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Discussing something you have already been doing — the long version Replied, post #19 · Clinical › Prescriber conversations · 13 Jul 2025 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #53 · Compounds › Semaglutide · 3 Jul 2025 · 5 likes This follows post #50 rather than contradicting it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #69 · Clinical › Comorbidities · 19 Jun 2025 · 0 likes Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Substitution between formats during a shortage Replied, post #8 · Access › Shortages · 11 Jun 2025 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #7 · Compounds › Oral incretins · 6 Jun 2025 · 1 like Worth separating two things that post #3 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #54 · Compounds › Repair & healing peptides · 5 Jun 2025 · 25 likes Picking up post #51: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Which panel is worth repeating and which is worth ignoring Replied, post #29 · Clinical › Bloodwork · 31 May 2025 · 9 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #109 · Outcomes › Body composition · 28 May 2025 · 6 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #28 · Meta › Wiki maintenance · 10 May 2025 · 17 likes This follows post #25 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #35 · Sourcing › Independent verification · 8 May 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Regression to the mean in progress reports Replied, post #6 · Research Methods › Statistics · 3 May 2025 · 1 like Coming back to post #4, because the follow-up matters more than the original answer. Effect sizes: the magnitude of a difference, not just whether it is statistically…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #11 · Outcomes › Progress reports · 24 Apr 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
When to suspect the method rather than the sample Replied, post #105 · Analytics › Method validation · 28 Mar 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #62 · Evidence › Journal club · 25 Mar 2025 · 28 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #70 · Documentation › Doc review · 22 Mar 2025 · 12 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #119 · Compounds › Other compounds · 19 Mar 2025 · 1 like On post #115 — agreed on the reasoning, with one qualification. Reading a supplier's product description as a marketing document: that is exactly what it is. The…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #18 · Start Here › Welcome · 17 Mar 2025 · 19 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Charge states for a 4 kDa peptide, worked through Replied, post #17 · Analytics › Mass spectrometry · 4 Mar 2025 · 13 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #24 · Analytics › Mass spectrometry · 3 Mar 2025 · 32 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #26 · Documentation › Doc review · 18 Jan 2025 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Recovery when intake is low: what to cut first Replied, post #50 · Nutrition & Training › Resistance training · 12 Jan 2025 · 10 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #124 · Compounds › Tirzepatide · 2 Jan 2025 · 33 likes Worth separating two things that post #120 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
People with a low starting BMI: where the evidence stops Replied, post #27 · Clinical › Special populations · 26 Dec 2024 · 9 likes post #26 answers the question as asked. The question underneath it is different. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments…
-
[2026 update] New subcategory: rationale and scope Replied, post #85 · Meta › Announcements · 22 Dec 2024 · 11 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
When "no data" is the complete and final answer Replied, post #47 · Compounds › Other compounds · 22 Dec 2024 · 5 likes post #46 answers the question as asked. The question underneath it is different. Reading a supplier's product description as a marketing document: that is exactly what…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #28 · Practice › Side effects · 19 Nov 2024 · 14 likes Worth separating two things that post #24 runs together. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #27 · Sourcing › Independent verification · 11 Nov 2024 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. How to submit a sample: contact the service directly. They will provide…
-
Time to steady state after a dose increase Replied, post #114 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Coming back to post #112, because the follow-up matters more than the original answer. Individual variation: people vary in how quickly they absorb, distribute,…
-
Requesting a page: what makes a good request — what changed since Replied, post #60 · Documentation › Wiki requests · 11 Oct 2024 · 9 likes Picking up post #57: that is the part I would want checked first. Cross-referencing: if you notice two pages that should reference each other but do not, suggest the…
-
Progressive overload when the scale is falling — one year on Replied, post #102 · Nutrition & Training › Resistance training · 28 Sep 2024 · 17 likes On post #98 — agreed on the reasoning, with one qualification. Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18…
-
Correlation in a self-tracked dataset: what it can support Replied, post #93 · Research Methods › Statistics · 24 Aug 2024 · 28 likes post #92 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #9 · Practice › Dosing & titration · 6 Jul 2024 · 6 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
Assessing a warm arrival: the decision process — one year on Replied, post #80 · Sourcing › Logistics · 31 May 2024 · 4 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…